TGFB1 and glioblastoma: Other study reported a transfer of transglutaminase responsible for increase of mitogenic signaling in cells treated with GBM-EVs (Antonyak et al., 2011), and TGF-β (transforming growth factor beta), the cytokine with potent immune suppressive activity (Graner et al., 2009) in primary GBM cell lines.